OTHER GROUP COMPANIES
market

Unichem Lab receives ANDA nod for Aripiprazole Tablets from USFDA; Stock skyrockets over 15% today

Aripiprazole tablets are indicated for Schizophrenia and Irritability associated with Autistic Disorder.

December 03, 2021 12:42 IST | India Infoline News Service
Unichem
Unichem Laboratories has received ANDA approval for its Aripiprazole Tablets USP, 2 mg, 5 mg, 10 mg, 15 mg, 20 mg, and 30 mg from the United States Food and Drug Administration (USFDA) to market a generic version of Abilify Tablets, 2 mg, 5 mg, 10 mg, 15 mg, 20 mg, and 30 mg, of Otsuka Pharmaceutical Company.

Aripiprazole tablets are indicated for Schizophrenia and Irritability associated with Autistic Disorder.

The product will be commercialized from Unichem’s Ghaziabad Plant.

On Friday, Unichem Lab stock skyrocketed more than 15% on Sensex with an intraday high of Rs257 per piece.

At around 12.41 pm, Unichem Lab was trading at Rs252.45 per piece up by Rs29.20 or 13.8% on Sensex.

The stock has opened at Rs231.40 per piece on the 30-scrip index. 

OPEN A DEMAT ACCOUNT & Get
FREE Benefits Worth 5,000

FEATURED ARTICLE

BLOGS

Open Demat Account

  • 0

    Per Order for ETF & Mutual Funds Brokerage

  • 20

    Per Order for Delivery, Intraday, F&O, Currency & Commodity